✦ LIBER ✦

Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993–2007

✍ Scribed by S. A. McDonald; S. J. Hutchinson; S. Cameron; S. M. Bird; P. R. Mills; A. McLeod; D. J. Goldberg

Book ID: 108886520
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 50 KB
Volume: 18
Category: Article
ISSN: 1352-0504
DOI: 10.1111/j.1365-2893.2010.01377.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Management of Hepatitis C in Patients wi

Management of Hepatitis C in Patients with End-stage Renal Disease

✍ Marina Berenguer; Victoria Aguilera 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 251 KB

Percutaneous Liver Biopsy Is Safe in Chr

Percutaneous Liver Biopsy Is Safe in Chronic Hepatitis C Patients With End-Stage Renal Disease

✍ Pawa, Swati; Ehrinpreis, Murray; Mutchnick, Milton; Janisse, James; Dhar, Ravi; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 115 KB

Famciclovir treatment of hepatitis B inf

Famciclovir treatment of hepatitis B infection in patients with end-stage liver disease

✍ M. Manns; P. Neuhaus; H. Schoenborn; K.E. Griffin 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Treatment of hepatitis C virus infection

Treatment of hepatitis C virus infection in patients with end-stage renal disease

✍ Chen-Hua Liu; Jia-Horng Kao 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Mayo end-stage liver disease (MELD) scor

Mayo end-stage liver disease (MELD) score: Causes of variablitity in patients with end-stage liver disease (ESLD)

✍ Yousfi, Mahmound M.; Douglas, David D.; Malinchoc, Michael; Mulligan, David C.; 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Hepatic encephalopathy as a predictor of

Hepatic encephalopathy as a predictor of survival in patients with end-stage liver disease

✍ Charmaine A. Stewart; Michael Malinchoc; W. Ray Kim; Patrick S. Kamath 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 2 views

Hepatic encephalopathy (HE) is an important component of hepatic decompensation, which reduces survival in patients with cirrhosis. The Model for End-Stage Liver Disease (MELD) score has been used to predict survival of patients with cirrhosis. The aims of this study were to determine whether HE is